|
|
||||||||
J Thorac Cardiovasc Surg 2009;137:1556-1557
© 2009 The American Association for Thoracic Surgery
Brief Communication |
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Mo
Received for publication June 2, 2008; accepted for publication June 8, 2008. * Address for reprints: Jennifer S. Lawton, MD, Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8234, St Louis, MO 63110. (Email: lawtonj@wustl.edu).
| The first 20% of the full text of this article appears below. |
The third-generation Medtronic Mosaic porcine bioprosthesis (Medtronic Inc, Minneapolis, Minn) was introduced in 1994. The valve leaflets are fixed in glutaraldehyde at zero pressure (applying equal pressure to the inflow and outflow ends of the valve), the root is dilated to a pressure of 40 mm Hg ("physiologic fixation"), the fixed tissue is treated with
-aminooleic acid (a long-chain fatty acid that binds to the aldehyde fractions of the glutaraldehyde-preserved porcine tissue) to reduce calcification, and the tissue is mounted on a Hancock II (Medtronic Inc) flexible stent made of acetyl copolymer covered with Dacron fabric.1,2
Clinical Summary
The Medtronic Mosaic porcine valve has been reported to be both reliable and durable over time.1-4
The alarmingly early stenosis of an implanted Medtronic Mosaic
Related Article
J. Thorac. Cardiovasc. Surg. 2010 139: 1354.
This article has been cited by other articles:
![]() |
M. Celiento, G. Ravenni, A. D. Milano, S. Pratali, G. Scioti, C. Nardi, and U. Bortolotti Aortic Valve Replacement With the Medtronic Mosaic Bioprosthesis: A 13-Year Follow-Up Ann. Thorac. Surg., February 1, 2012; 93(2): 510 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Peeceeyen, C. Cao, G. Fermanis, and C. Manganas Early stenosis of Medtronic Mosaic bioprosthesis in the aortic position J. Thorac. Cardiovasc. Surg., February 1, 2012; 143(2): e13 - e14. [Full Text] [PDF] |
||||
![]() |
B. Meuris and W. Flameng Relation between hemodynamic behavior and occurrence of early stenotic failure of bioprostheses J. Thorac. Cardiovasc. Surg., November 1, 2010; 140(5): 1200 - 1200. [Full Text] [PDF] |
||||
![]() |
W. R. E. Jamieson and G. J. Fradet Reply to the Editor J. Thorac. Cardiovasc. Surg., November 1, 2010; 140(5): 1200 - 1201. [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola Choice of Prosthetic Heart Valve in Adults: An Update J. Am. Coll. Cardiol., June 1, 2010; 55(22): 2413 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. E. Jamieson and G. J. Fradet Aortic bioprosthesis--avoid obstructive properties due to thrombosis as altered durability due to structural valve deterioration J. Thorac. Cardiovasc. Surg., May 1, 2010; 139(5): 1354 - 1354. [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., April 20, 2010; 55(16): 1729 - 1742. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |